African Journal of
Pharmacy and Pharmacology

  • Abbreviation: Afr. J. Pharm. Pharmacol.
  • Language: English
  • ISSN: 1996-0816
  • DOI: 10.5897/AJPP
  • Start Year: 2007
  • Published Articles: 2225

Full Length Research Paper

Prevalence and the level of evidences supporting off-label prescribing of antidepressant, antipsychotic and antiepileptic drugs in Makkah Almukarramah: A case sectional study

Yosra Al-Hindi
  • Yosra Al-Hindi
  • Department of clinical pharmacy, Faculty of Pharmacy, University of Umm Al-Qura, Makkah, Saudi Arabia.
  • Google Scholar
Amal Al-sulami
  • Amal Al-sulami
  • Department of clinical pharmacy, Faculty of Pharmacy, University of Umm Al-Qura, Makkah, Saudi Arabia.
  • Google Scholar
Aseel Al-ghamdi
  • Aseel Al-ghamdi
  • Department of clinical pharmacy, Faculty of Pharmacy, University of Umm Al-Qura, Makkah, Saudi Arabia.
  • Google Scholar
Nuha Al-Harbi
  • Nuha Al-Harbi
  • Department of clinical pharmacy, Faculty of Pharmacy, University of Umm Al-Qura, Makkah, Saudi Arabia.
  • Google Scholar
Huda Hamdi
  • Huda Hamdi
  • Department of clinical pharmacy, Faculty of Pharmacy, University of Umm Al-Qura, Makkah, Saudi Arabia.
  • Google Scholar
Shooq Al-moqati
  • Shooq Al-moqati
  • Department of clinical pharmacy, Faculty of Pharmacy, University of Umm Al-Qura, Makkah, Saudi Arabia.
  • Google Scholar
Yara Abualkair
  • Yara Abualkair
  • Department of clinical pharmacy, Faculty of Pharmacy, University of Umm Al-Qura, Makkah, Saudi Arabia.
  • Google Scholar
Arwa Fairaq
  • Arwa Fairaq
  • Department of clinical pharmacy, Faculty of Pharmacy, University of Umm Al-Qura, Makkah, Saudi Arabia.
  • Google Scholar


  •  Received: 21 March 2020
  •  Accepted: 20 May 2020
  •  Published: 30 June 2020

References

Anderson SL, Griend JP (2014). Quetiapine for insomnia: A review of the literature. American Journal of Health-System Pharmacy 71(5):394-402.
Crossref

 

Bashawri H (2013). Sleepless in Makkah City, Saudi Arabia: Prevalence and Risk Factors of Insomnia and the Variations in Sleep Quality among Visitors of Primary Health Care Centers. MPH. Emory University.

 

Botts SR, Raskind J (1999). Gabapentin and lamotrigine in bipolar disorder. American Journal of Health-System Pharmacy 56(19):1939-1944. 
Crossref

 

Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD (1999). A Double-Blind Placebo-Controlled Study of Lamotrigine Monotherapy in Outpatients With Bipolar I Depression. The Journal of Clinical Psychiatry 60(2):79-88. 
Crossref

 

Eguale T, Buckeridge DL, Verma A, Winslade NE, Benedetti A, Hanley JA, Tamblyn R (2016). Association of Off-label Drug Use and Adverse Drug Events in an Adult Population. JAMA Internal Medicine 176(1):55. 
Crossref

 

Eguale T, Buckeridge DL, Winslade NE, Benedetti A, Hanley JA, Tamblyn R (2012). Drug, Patient, and Physician Characteristics Associated With Off-label Prescribing in Primary Care. Archives of Internal Medicine 172(10): 
Crossref

 

Franco V, Canevini MP, Capovilla G, Sarro GD, Galimberti CA, Gatti G, Perucca E (2014). Off-Label Prescribing of Antiepileptic Drugs in Pharmacoresistant Epilepsy: A Cross-Sectional Drug Utilization Study of Tertiary Care Centers in Italy. CNS Drugs 28(10):939-949. 
Crossref

 

Fukada C, Kohler JC, Boon H, Austin Z, Krahn M (2012). Prescribing Gabapentin off Label: Perspectives from Psychiatry, Pain and Neurology Specialists. Canadian Pharmacists Journal / Revue Des Pharmaciens Du Canada 145(6). 
Crossref

 

Kamath L (2017). Cost variation analysis study of oral anti-depressant drugs available in India. International Journal of Basic and Clinical Pharmacology 6(4):973.
Crossref

 

Maher AR, Maglione M, Bagley S, Suttorp M, Hu J, Ewing B, Shekelle PG (2011). Efficacy and Comparative Effectiveness of Atypical Antipsychotic Medications for Off-Label Uses in Adults. Jama 306(12):1359. 
Crossref

 

Mercier A, Auger-Aubin I, Lebeau J, Schuers M, Boulet P, Hermil J, Peremans L (2013). Evidence of prescription of antidepressants for non-psychiatric conditions in primary care: An analysis of guidelines and systematic reviews. BMC Family Practice 14(1). 
Crossref

 

Onyenwenyi AJ (2008). Off-label prescribing of anticonvulsant drugs. (Order No. 3381471, University of Florida). ProQuest Dissertations and Theses, p. 184.

 

Park Susie H, Pharm D, BCPP, FCSHP (2013). Off-label use of atypical antipsychotics: Lack of evidence for their use in primary insomnia. Formulary 48(11):361-362,365-368,370-376. 

 

Rahajeng B, Ikawati Z, Andayani TM, Dwiprahasto I (2018). A Retrospective Study: The Off-Label Use Of Anticonvulsants At A Private Hospital In Indonesia. International Journal of Pharmacy and Pharmaceutical Sciences 10(5):119. 
Crossref

 

Sartori SB, Singewald N (2019). Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders. Pharmacology and Therapeutics 107402.
Crossref

 

Shrestha R, Prajapati S (2019). Assessment of prescription pattern and prescription error in outpatient Department at Tertiary Care District Hospital, Central Nepal. Journal of Pharmaceutical Policy and Practice 12(1):16.
Crossref

 

Varghese D, Carroll N (2015). Resource Utilization and costs associated with off-label use of atypical Antipsychotics in a Community-Dwelling Adult Population: Findings from the Medical Expenditure Survey. Value in Health 18(3):
Crossref

 

Walton SM, Schumock GT, Lee K, Alexander GC, Meltzer D, Stafford RS (2008). Prioritizing Future Research on Off-Label Prescribing: Results of a Quantitative Evaluation. Pharmacotherapy. The Journal of Human Pharmacology and Drug Therapy 28(12):1443-1452. 
Crossref

 

Wittich CM, Burkle CM, Lanier WL. (2012). Ten common questions (and theiranswers) about off-label drug use. Mayo Clinic Proceedings. 356:982-90.
Crossref

 

Wong J, Motulsky A, Abrahamowicz M, Eguale T, Buckeridge DL, Tamblyn R (2017). Off-label indications for antidepressants in primary care: Descriptive study of prescriptions from an indication based electronic prescribing system. BMJ 356, j603.
Crossref

 

Wong J, Motulsky A, Eguale T, Buckeridge DL, Abrahamowicz M, Tamblyn R (2016). Treatment Indications for Antidepressants Prescribed in Primary Care in Quebec, Canada, 2006-2015. Jama 315(20):2230.
Crossref